Navigation Links
A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
Date:11/12/2008

BOSTON, Nov. 12 /PRNewswire/ -- WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" -- often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predictions of upcoming influenza strains, approximately 36,000 people die each year of flu in the United States alone.

As in the case of hurricanes, early warning of the location and intensity of virus outbreaks would allow us more rapidly and effectively to defend ourselves with strain-specific vaccines. This is now possible.

To provide this vital knowledge, Drs. Samuel and Elenore Bogoch of the Foundation for Research on the Nervous System and Replikins Ltd. of Boston ("Replikins") are presenting new technology at the 7th International Bird Flu Summit in Las Vegas November 13-14, 2008 that can accurately predict which viral strains are poised to attack human populations, and reveal the location from which this viral strain is going to strike. This service is being offered to WHO and CDC.

The key to this predictive technology is a new class of structural virus peptides that have been shown to be involved in the chemistry of rapid replication. The Drs. Bogoch called them "Replikins," and they are strictly defined by the concentration of lysine and histidine residues and the spacing between them. To demonstrate the correlation between the concentration of replikins and the lethality of influenza virus outbreaks, Replikins Ltd. has developed software called FluForecast(R), which counts the number of replikins in the sequences of each strain of flu virus across the years -- and thanks to the data in public databases like PubMed, we now can track as far as 90 years back.

What Replikins have found is that there's a strong correlation between the concentration of replikins and the lethality of an influenza virus outbreak. This allows us to determine in advance
'/>"/>

SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
2. James L. Wittliff, Ph.D., FACB, to Present Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System at the Association for Molecular Pathology Conference, October 30
3. Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
4. Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report
5. New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development
6. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
7. In Pain Market, Huge Unmet Needs, Tough Regulatory Environment Challenge Pharmaceutical Companies, According to MedPredict
8. Thought Leaders Discuss Positive Outlook for Bapineuzumab in Alzheimers Disease in MedPredict Report
9. Computer predicts anti-cancer molecules
10. New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated
11. Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Spherix Incorpora...y for diabetes therapy, and a provider of technica...lement, biotechnology and pharmaceutical companies...d $6.3 million registered direct placement to inst...mon stock and warrants to purchase up to 1,104,348...
(Date:11/19/2009)...wswire-FirstCall/ -- Spherix Incorporated (Nasdaq:...es therapy, and a provider of technical and regula...echnology and pharmaceutical companies, today anno...hareholders. ,, At the meeting, shareholders of... following members to the Board of Directors: ,...
(Date:11/19/2009)...ember 19 MONITORING FORCE GmbH,ann... Flibanserin in the,indication treatment-relevant ... for orphan drug status designation with the Europ...inesia is a complication of the mainstay,treatment...ome of those,affected, since it may be disabling f...
(Date:11/19/2009)...geons and recognized refractive and cataract surge...rought their fellow surgeons up-to-date on the lat...aract surgery, and ophthalmology in general at the...ogy (AAO) annual meeting in San Francisco, Califor.... David Huang, MD, Dr. Randy Epstein, Dr. William ...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
... 17 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ..., today announced that its lead product candidate,...uct designation for the treatment of,small cell lu...designation,is based on a recommendation from the ...the European Medicines Agency (EMEA). Picoplatin ...
...lt announced today that,the Henry C. Witelson Ocul...ealth Centre has purchased a Personal Archive bios... in Montreal, Quebec. GenVault technology will be... in determining the mechanisms underlying eye canc...for developing new approaches for,treatment. These...
...ea Pharmaceuticals,Inc. announced today that BC De...diagnostic test, is now available from Panacea Lab...at should facilitate the identification,of recurre...ncer. Panacea,Laboratories, a division of Panacea ...aboratory Improvement Amendments of 1988 (CLIA). T...
Other Biology Technology:Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 3Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 4McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 3Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 4
(Date:11/23/2009)... The National Institute of General Medical Science...th (NIH), is investing $42.3 million for grants in...ities (GO)." NIH developed the GO grant program to...ng funds provided by the American Recovery and Rei...und projects that promise to have a significant im...
(Date:11/23/2009)... This release is available in German . , A...trument wouldn,t be a bad thing. It could help to ... to measure. However, it must do so constructively...l measurement with more than just imagination, phy...cs have formulated a theory of spatial perception ...
(Date:11/22/2009)... A team of pioneering South Korean scientists have...yday plastics through bioengineering, rather than ...is groundbreaking research, which may now allow fo...tics, is published in two papers in the journal B...al,s 50th anniversary. , Polymers are molecules...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Bioengineers succeed in producing plastic without the use of fossil fuels 2PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 1PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 2PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 3The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 1The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 2The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 3Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 1Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 2Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 3Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 4Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 5Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 6
...lop a clearer picture of what makes some people st...esearchers who last year identified the first comm...entified a further twenty regions of the genome wh... 6cm. , The results, published together with two...ature Genetics, mean that scientists now know of d...
...(HHMI) researchers have found that rare mutations ...ion in the general population. , The scientists ha...t handling genes cause several rare diseases that ...cing DNA samples obtained from 3,125 people who ar... researchers identified new functional mutations i...
...m, controls many metabolic functions and is based ...r cycle that is important in determining sleeping ... biological processes in mammals. , The newly dis...tes in the hypothalamus, a region of the brain tha...onomic nervous system. But unlike the circadian rh...
Other Biology News:A tall story: New research adds to growing body of knowledge of genetics of height 2Rare genetic mutations protect against hypertension 2Rare genetic mutations protect against hypertension 3Rare genetic mutations protect against hypertension 4NYU dental professor discovers biological clock linking tooth growth to other metabolic processes 2
...00A can be upgraded to the GenePix Autoloader 4200...ans, analyzes, and saves results for up to 36 slid...omplete. Line-by-line autofocus ensures superior f...ro gives you complete flexibility to configure sca...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
...microarray data using Asuragens bioinformatics exp...ation to extensive data analysis using the most up...tion with the Gene Expression Profiling Service or...lization and basic statistical analysis including ...
Illumina Standard Data Analysis Report from Asuragen, Inc.
Biology Products: